| Literature DB >> 10790591 |
M Lombès1, N Farman, J P Bonvalet, M C Zennaro.
Abstract
The cardiovascular system is now recognized as an important mineralocorticoid target. All -components required for specific and selective aldosterone effects are present in the cardiovascular system. Mineralocorticoid receptors (MR) are expressed in the heart and large blood vessels together with the 11 B-hydroxysteroid dehydrogenase type II, which ensures the enzymatic protection of MR against glucocorticoids. The recent description of local vascular and cardiac aldosterone biosynthesis strongly supports an autocrine/paracrine hormonal action. Establishment of transgenic mice models of targeted overexpression of the mineralocorticoid receptor should facilitate new insights into the molecular and cellular mechanisms of aldo-sterone actions in the cardiovascular system.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10790591
Source DB: PubMed Journal: Ann Endocrinol (Paris) ISSN: 0003-4266 Impact factor: 2.478